← Open Payments lookup

MAZHAR KHOWAJA: Open Payments

NPI 1770523276 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$159,571 in 186 payments from 5 companies in 2025. Trend: 2023 $235,333 · 2024 $176,848 · 2025 $159,571

Speaker / faculty: $114,781Consulting: $23,750Travel & lodging: $16,736Food & beverage: $4,304
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.138$129,722
ACADIA Pharmaceuticals Inc37$29,469
Otsuka America Pharmaceutical, Inc.9$236
E.R. Squibb & Sons, L.L.C.1$122
Teva Pharmaceuticals USA, Inc.1$22

Products named: INGREZZA, NUPLAZID, REXULTI, COBENFY, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.